Key result
Preincubation with the ETA receptor antagonist BQ123 significantly enhanced acetylcholine-induced relaxation in subcutaneous arteries from obese hypertensive women from 51.5% to 77.0% (p<0.001).
Why the study?
Does the ET(A) receptor antagonist BQ123 improve endothelium-dependent relaxation in arteries from obese hypertensive women?
Case-Control (n=16)
No
Does the ET(A) receptor antagonist BQ123 improve endothelium-dependent relaxation in arteries from obese hypertensive women?
Endothelin A receptor blockade with BQ123 improves endothelium-dependent relaxation in arteries from obese hypertensive women, suggesting a potential therapeutic target for blood pressure reduction in this population.
Hypertension in obesity is associated with increased insulin resistance, vascular mass and body mass index (BMI). The purpose of the study was to visualize endothelin-1 (ET-1) mediated constriction in arteries isolated from subcutaneous adipose tissue from obese hypertensive women previously operated by gastric bypass. Functional studies were conducted in a microvascular myograph. Expressed as percentage of contraction elicited by 124 mM KCl concentration-response curves for ET-1 were shifted leftward in arteries from obese hypertensive patients compared to healthy normotensive subjects. The vasodilator response to the ET-1 antagonist BQ123 (1 microM) was significantly higher in arteries from obese hypertensive patients (p<0.001). BQ123 induced relaxation was inhibited by NO synthase inhibitor L-NAME (0.1 nM). Preincubation with BQ123 enhanced the relaxation induced by acetylcholine (ACh; 0.1 nM - 0.1 mM) (p<0.001), but not that induced by NO donor sodium nitroprusside (SNP; 0.1 nM - 0.1 mM), in arteries from obese hypertensive patients. The present study show that hypertension yet prevail after gastric bypass surgery and the ET(A) receptor antagonist BQ123 may be a useful tool in reducing blood pressure in obese hypertensive patients.
No takes yet. Share an insight, caveat, or question.
Gradin et al. (2018) conducted a case-control in Obesity and hypertension post-gastric bypass (n=16). ETA receptor antagonist BQ123 vs. Absence of BQ123 (baseline conditions) was evaluated on Maximal relaxation to acetylcholine (ACh) in precontracted arteries (p=<0.001). Preincubation with the ETA receptor antagonist BQ123 significantly enhanced acetylcholine-induced relaxation in subcutaneous arteries from obese hypertensive women from 51.5% to 77.0% (p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: